New England Research & Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,100	Closed	-$607K	–	134
2020 Q2	$607K	Buy	+4,100	New	+$607K	0.43%	81